ARCUS BIOSCIENCES INC (RCUS)

US03969F1093 - Common Stock

15.23  -0.33 (-2.12%)

Full estimates are only available for subscribed users, you can see which data is available below.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031
Revenue
YoY % growth
382.9M
394.06%		112M
-70.75%		117M
4.46%		195.49M
67.09%
EBITDA
YoY % growth
58M
147.89%		-274M
-572.41%		-332M
-21.17%		-256.617M
22.71%		N/AN/AN/AN/AN/A
EBIT
YoY % growth
54.2M
143.64%		-280M
-616.61%		-340M
-21.43%		-335.213M
1.41%
Operating Margin
14.16%-250.00%-290.60%-171.47%
EPS
YoY % growth
0.43
118.30%		-3.72
-965.12%		-4.15
-11.56%		-3.59
13.39%		N/A

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q1 / 24 Q2 / 24 Q3 / 24 Q4 / 24 Q1 / 25 Q2 / 25 Q3 / 25 Q4 / 25 Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26
EPS
Q2Q % growth		-0.95
13.01%
Revenue
Q2Q % growth		36.268M
45.07%
EBITDA
Q2Q % growth		-88.928MN/AN/AN/AN/AN/AN/AN/AN/AN/A
EBIT
Q2Q % growth		-91.882M
-6.84%		N/AN/AN/AN/A

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q4 2023
Q2Q % growth		 -1.08
-16.13%		-1.04-0.04-3.39%
Q3 2023
Q2Q % growth		 -0.94
-4.44%		-1.150.2118.35%
Q2 2023
Q2Q % growth		 -1.04
-11.83%		-1.120.087.19%
Q1 2023
Q2Q % growth		 -1.09
-13.54%		-1.190.108.14%
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q4 2023
Q2Q % growth		 31M
-8.01%		28.935M2.065M7.14%
Q3 2023
Q2Q % growth		 32M
-4.76%		27.828M4.172M14.99%
Q2 2023
Q2Q % growth		 29M
8.21%		30.904M-1.904M-6.16%
Q1 2023
Q2Q % growth		 25M
38.89%		25.467M-467K-1.83%
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS1.2% 12.51% -7.31% 13.71%
Revenue0% -3.38% -5.64% 26.42%